Category: eCTD

NextGen eCTD Software Supported Country Tunisia: Transforming Regulatory Submissions with Masuu Global The pharmaceutical regulatory system of Tunisia continues to improve, and NextGen eCTD supported country Tunisia becomes an important target for those enterprises who seek effective ways of entering into the market.

NextGen eCTD Software Supported Country Ukraine: Transforming Regulatory Submissions with Masuu Global Ukraine is gradually modernizing its pharmaceutical control system, and NextGen eCTD supported country Ukraine is a significant target of companies intending to expand to this market.

FDA Adverse Event Monitoring System (AEMS) Electronic Submissions: Streamlining Regulatory Safety Reporting The FDA Adverse Event Monitoring System (AEMS) Electronic Submissions framework marks a transformative step in modernizing regulatory safety reporting. Replacing the former FDA Adverse Event Reporting System (FAERS), AEMS introduces a unified, centralized platform designed to improve the quality, consistency, and efficiency of… Continue reading FDA Adverse Event Monitoring System (AEMS) Electronic Submissions: Streamlining Regulatory Safety Reporting

NextGen eCTD  Software Supported by WHO: Advancing Global Regulatory Submissions with Masuu Global The world pharmaceutical sector is changing fast and NextGen eCTD Software supported by WHO is emerging as a main force behind harmonized, efficient regulatory submissions.

NextGen eCTD Software Supported Country Kuwait: Preparing for MOH Compliance and 2025 eCTD Mandate Kuwait is gradually improving its pharmaceutical regulatory system and NextGen eCTD software supported country Kuwait is one of the critical factors that companies should take into account when entering the country successfully.

The Complete EU eCTD Submission Checklist for 2026 As regulations continue to change, it’s essential to have a solid submission checklist to succeed in Europe. The European Medicines Agency and other governing bodies maintain strict compliance standards. Remember, when crafting your responses, always stick to the specified language and avoid using any others. Keep in… Continue reading The Complete EU eCTD Submission Checklist for 2026

Streamlining EU eCTD Submissions for Better Compliance and Speed The filing of regulatory dossiers in Europe has continued to get complicated as standards are changing between the European Medicines Agency and other health regulating authorities.

Mastering EU eCTD Submissions: Strategies for Compliance and Success EU eCTD Submissions have become increasingly complex as regulatory standards continue to evolve across Europe. The filing of regulatory dossiers is no longer straightforward, with changing expectations from the European Medicines Agency and other health authorities.

EU eCTD Submissions 2026: Key Updates from EMA European regulatory environment is still kept changing, and the European Medicines Agency (EMA) has been proposing essential changes to the EU eCTD submissions. In the case of pharmaceutical and life sciences firms that focus on Europe, compliance is no longer a choice to make but a necessity… Continue reading EU eCTD Submissions 2026: Key Updates from EMA

eCTD Guidance for Marketing Authorisation and Post-Authorisation Applications in Europe: A 2026 Regulatory Perspective Most of the regulatory processes in Europe are required to submit Electronic Common Technical Document (eCTD). Standardized electronic dossiers are required by the European Medicines Agency (EMA) and national competent authorities of the Marketing Authorisation Application (MAA) and the Post-Authorisation Application… Continue reading eCTD Guidance for Marketing Authorisation and Post-Authorisation Applications in Europe: A 2026 Regulatory Perspective